Drug intelligence / Profile preview

desflurane + remifentanil

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Inhalation, Intravenous
01

Overview

The combination of desflurane and remifentanil is a balanced anesthesia approach used in various surgical procedures. This combination leverages the complementary properties of both agents to provide effective anesthesia with favorable recovery profiles. ## Pharmacological Properties Desflurane is a volatile inhalational anesthetic with low blood solubility, allowing for rapid induction and emergence from anesthesia[8]. Remifentanil is an ultra short-acting synthetic opioid with rapid onset and offset of action, making it ideal for continuous infusion during surgical procedures[5]. When used together, remifentanil reduces the required concentration of desflurane in a dose-dependent manner. Studies have shown that remifentanil at doses of 0.1, 0.15, or 0.25 μg/kg/min can reduce desflurane requirements by 74%, 83%, and 90% respectively[1]. This synergistic effect allows for lower concentrations of desflurane while maintaining adequate anesthesia. ## Clinical Applications The desflurane-remifentanil combination has been successfully used in various surgical settings: - General surgery and ambulatory procedures[6] - Otorhinolaryngeal surgery[7] - Tympanoplasty and endoscopic sinus surgery[4] - Cesarean section deliveries[3] - Laparoscopic procedures[6] ## Advantages This combination offers several clinical benefits: 1. **Improved hemodynamic stability**: The combination helps maintain stable blood pressure and heart rate during surgery[3]. 2. **Faster recovery**: Studies show shorter emergence times and faster achievement of discharge criteria compared to other anesthetic regimens[6][7]. 3. **Dose-dependent effects**: Remifentanil reduces desflurane requirements without increasing recovery time, allowing for tailored anesthesia[1][2]. 4. **Effective hypotensive anesthesia**: The combination provides good surgical conditions in terms of operative field quality, particularly beneficial in procedures where bleeding control is important[4]. ## Recommended Dosing For optimal results, studies recommend using remifentanil at 2 ng/ml or less combined with desflurane to decrease the concentration of desflurane without significant side effects during the maintenance phase of anesthesia[2]. Typical infusion rates range from 0.05 to 0.2 μg/kg/min for remifentanil alongside variable concentrations of desflurane (2-8%)[6]. ## Safety Considerations While generally well-tolerated, the combination may cause dose-dependent decreases in heart rate, particularly at higher remifentanil doses (0.15 or 0.25 μg/kg/min)[1]. However, studies have shown no significant differences in postoperative nausea and vomiting, pain, or the need for rescue medications compared to other anesthetic regimens[6]. In cesarean section procedures, the combination has been shown to be safe for both mother and newborn, with no significant impact on Apgar scores or umbilical artery blood pH values[3].

Other names
Desflurane with remifentanil
02

Targets

GLRA1 (Glycine receptor subunit Alpha-1)MOR (Mu opioid receptor)GRIA1 (AMPA receptor subunit GluA1)

Beyond the preview

Go deeper on desflurane + remifentanil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desflurane + remifentanil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call